PMN - ProMIS Neurosciences Inc.
11.445
-0.085 -0.743%
Share volume: 57,500
Last Updated: 04-20-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$11.53
-0.08
-0.01%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-12-2025 | 08-13-2025 | 11-12-2025 | 03-25-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 7.460 M | 10.185 M | 11.750 M | 10.772 M | |
| Selling general and admin | 1.996 M | 1.435 M | 1.953 M | 1.404 M | |
| Research and development | 5.464 M | 8.750 M | 9.797 M | 9.368 M | |
| Total expenses | 7.460 M | 10.185 M | 11.750 M | 10.772 M | |
| 36.52% | 15.37% | -8.33% | |||
| Operating income | -7.460 M | -10.185 M | -11.750 M | -10.772 M | |
| Ebit | -7.348 M | -10.117 M | -11.580 M | -10.680 M | |
| Pretax income | -7.348 M | -10.117 M | -11.580 M | -10.680 M | |
| 37.69% | 14.46% | -7.78% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.348 M | -10.117 M | -11.580 M | -10.674 M | |
| -37.69% | -14.46% | 7.82% |